Zobrazeno 81 - 90
of 142
pro vyhledávání: '"Dan Xu"'
Publikováno v:
International journal of biological macromolecules. 107
PTP, one polysaccharide extracted from the roots of Polygala tenuifolia , has displayed anti-cancer activity in several types of ovarian cancer cells. This study aims to elucidate the structure of PTP and investigate its anticancer effects against SK
Autor:
Yi Nan Wang, Feng Guang Gao, Nan Nan Lu, Dan Dan Xu, Yue Hua Zhang, Shi Zhong Ke, Hua Xiu Sui
Publikováno v:
International journal of oncology. 51(3)
Cholinergic anti-inflammatory pathway has therapeutic effect on inflammation-associated diseases. However, the exact mechanism of nicotine-mediated anti-inflammatory effect is still unclear. TIPE2, a new member of tumor necrosis factor-α-induced pro
Autor:
Jie Ping, Dan Xu, Lian Liu, Zheng He, Lu Ma, Hui Wang, Zixin Deng, Hao Kou, Hanwen Luo, Liaobin Chen, Lang Shen
Publikováno v:
Toxicology and Applied Pharmacology. 274:383-392
Our previous studies have demonstrated that prenatal caffeine ingestion induces an increased susceptibility to metabolic syndrome with alterations of glucose and lipid metabolic phenotypes in adult first generation (F1) of intrauterine growth retarda
Publikováno v:
Scientific Reports
Cigarette smoke (CS) is a major risk of chronic obstructive pulmonary disease (COPD), contributing to airway inflammation. Our previous study revealed that silymarin had an anti-inflammatory effect in CS-exposed mice. In this study, we attempt to fur
Autor:
Dan-dan Xu, Peng-jun Zhou, Ying Wang, Yi Zhang, Rong Zhang, Li Zhang, Su-hong Chen, Bi-bo Ruan, Hai-peng Xu, Wu-yu Fu, Chao-zhi Hu, Lu Tian, Jin-hong Qin, Sheng Wang, Xiao Wang, Qiu-ying Liu, Zhe Ren, Xue-qui Gu, Yao-he Li, Zhong Liu, Yi Fei Wang
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 7 (2016)
Frontiers in Pharmacology, Vol 7 (2016)
Proliferation, a key feature of cancer cells, accounts for the majority of cancer-related diseases resulting in mortality. MicroRNAs (miRNAs) plays important post-transcriptional modulation roles by acting on multiple signaling pathways, but the unde
Autor:
Dan Han, Yunman Li, Jie Wei, Nian Xia, Dan Xu, Dongcheng Cai, Chen Shen, Yidong Feng, Rui Zhang, Weirong Fang, Wenhuan Ma
Publikováno v:
Scientific Reports
Hyperlipidemia aggravates myocardial ischemia/reperfusion (MI/R) injury through stimulating excessive inflammatory response. Therefore, blockade of inflammatory signal is a potential therapeutic management for MI/R complicated with hyperlipidemia. Hy
Publikováno v:
African Journal of Pharmacy and Pharmacology. 7:2907-2913
The latest published Linezolid in the treatment of subjects with nosocomial pneumonia proven to be due to methicillin-resistant Staphylococcus aureus (ZEPhyR) trial was a phase IV, randomized, double-blind, multicenter, comparator-controlled study co
Autor:
Hui Wang, Liaobin Chen, Dan Xu, Fenglong Cu, Youying Lei, Yu Deng, Jacques Magdalou, Hong Cao, Yang Tan
Publikováno v:
Toxicology and Applied Pharmacology
Toxicology and Applied Pharmacology, Elsevier, 2013, 269 (1), pp.25-33. ⟨10.1016/j.taap.2013.02.008⟩
Toxicology and Applied Pharmacology, Elsevier, 2013, 269 (1), pp.25-33. ⟨10.1016/j.taap.2013.02.008⟩
International audience; Previous studies have confirmed that maternal tobacco smoking causes ă intrauterine growth retardation (IUGR) and skeletal growth retardation. ă Among a multitude of chemicals associated with cigarette smoking, ă nicotine i
Autor:
Ji-Qiong Li, Jing An, Tao Wang, Dan Xu, Chun Wan, Lingli Guo, Zenglin Liao, Xiaoou Li, Jiajia Dong, Fuqiang Wen
Publikováno v:
European Journal of Pharmacology. 703:11-17
s Cigarette smoking is one of the risk factors for chronic obstructive pulmonary disease (COPD). In this study, we investigated the effects of thromboxane A2 (TxA2) receptor antagonists on airway mucus production induced by cigarette smoke. Rats were
Autor:
Yimeng Wu, Jie Liu, Yanzhuo Liu, C. Zhang, Jacques Magdalou, Dan Xu, Fulin Liu, Hui Wang, Lang Shen, Liaobin Chen, Youying Lei, Jun Qin, Jie Ping
Publikováno v:
Toxicology and Applied Pharmacology. 264:395-403
Caffeine is a definite factor of intrauterine growth retardation (IUGR). Previously, we have confirmed that prenatal caffeine ingestion inhibits the development of hypothalamic-pituitary-adrenal (HPA) axis, and alters the glucose and lipid metabolism